Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Rat APOBEC1 Protein

Cat.No. : APOBEC1-721R
Product Overview : Recombinant Rat APOBEC1 full length or partial length protein was expressed.
  • Specification
  • Gene Information
  • Related Products
Source : Mammalian Cells
Species : Rat
Tag : His
Form : Liquid or lyophilized powder
Endotoxin : < 1.0 EU per μg of the protein as determined by the LAL method.
Purity : >80%
Notes : This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Storage : Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC.
Storage Buffer : PBS buffer
Gene Name : Apobec1 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 [ Rattus norvegicus ]
Official Symbol : APOBEC1
Gene ID : 25383
mRNA Refseq : NM_012907.2
Protein Refseq : NP_037039.1
MIM :
UniProt ID : P38483

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (15)

Ask a question
Can APOBEC1 protein be targeted for cancer therapy? 02/16/2023

APOBEC1 protein has emerged as a potential target for cancer therapy due to its involvement in APOB mRNA editing and its role in tumor development. Inhibiting APOBEC1 activity could potentially restore the expression of full-length APOB protein in cancer cells, thereby inhibiting their growth and progression. However, further research is needed to develop specific and effective inhibitors of APOBEC1 for therapeutic purposes.

Is APOBEC1 protein expressed in tissues other than the intestine? 11/18/2022

While the highest expression of APOBEC1 protein is observed in the intestine, it can also be found in other tissues, albeit at lower levels. APOBEC1 expression has been detected in the liver, kidney, and colon, indicating potential roles in additional cellular processes beyond APOB mRNA editing. Research is ongoing to unravel the functions of APOBEC1 in these tissues.

Can APOBEC1 protein be a target for therapeutic interventions? 08/13/2022

Due to its involvement in lipid metabolism and its potential role in disease processes, APOBEC1 protein has been explored as a potential therapeutic target. Modulating the activity or expression of APOBEC1 could have implications for treating lipid disorders and other diseases associated with abnormal RNA editing processes. However, more research is needed to fully understand the potential therapeutic applications of targeting APOBEC1 protein.

Is APOBEC1 protein involved in any other biological processes? 05/31/2022

Besides its role in APOB mRNA editing, APOBEC1 protein has been implicated in other biological processes. It has been found to participate in RNA editing of other target RNA molecules and play a role in immune response modulation, viral restriction, and DNA mutagenesis.

Are there any diseases or conditions associated with dysregulation of APOBEC1 protein? 05/27/2022

Dysregulation of APOBEC1 protein has been implicated in several diseases and conditions. In addition to familial hypocholesterolemia type 2, alterations in the APOBEC1-mediated RNA editing process have been observed in certain liver cancers, where increased editing of APOB mRNA leads to reduced expression of full-length APOB protein. Furthermore, aberrant APOBEC1 activity has been linked to autoimmune diseases, such as systemic lupus erythematosus, where it contributes to the generation of autoantibodies.

Can APOBEC1 protein edit non-coding RNAs? 02/18/2022

Non-coding RNAs, such as long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), have been found to be targets of APOBEC enzymes. While APOBEC1 primarily acts on coding mRNAs, there is evidence that it can also edit non-coding RNAs. For example, APOBEC1 was shown to edit lncRNA H19, leading to altered stability and function of the RNA molecule. The extent and functional implications of APOBEC1-mediated editing on non-coding RNAs are still being investigated.

Are there any drugs or compounds that can modulate APOBEC1 activity? 07/05/2020

Currently, there are no specific drugs or compounds that directly target APOBEC1 activity. However, several approaches have been explored to modulate APOBEC1 function indirectly. For example, small molecules targeting the APOBEC1 cofactor, ACF, have been investigated to disrupt the APOBEC1-ACF interaction and inhibit APOB mRNA editing. Additionally, targeting upstream signaling pathways or post-translational modifications that regulate APOBEC1 activity could be potential strategies to modulate its function.

Are there any genetic mutations associated with APOBEC1 protein? 06/07/2020

Yes, genetic mutations in the APOBEC1 gene can lead to altered function or expression of APOBEC1 protein. These mutations can affect the RNA-editing process, causing dysregulation of APOB mRNA editing and resulting in abnormal lipid metabolism and increased cardiovascular disease risk.

Can APOBEC1 protein edit other mRNAs besides APOB mRNA? 05/18/2020

APOBEC1 protein is primarily known for its role in editing APOB mRNA. However, recent studies have suggested that it may have the potential to edit other mRNA molecules as well. For example, APOBEC1 has been found to edit the mRNA encoding the HPV E6 oncoprotein, leading to reduced viral replication. Additionally, APOBEC1-mediated RNA editing has been implicated in the regulation of other genes involved in lipid metabolism and liver function. Further research is needed to fully understand the extent and significance of APOBEC1's editing activity on non-APOB mRNAs.

What are the consequences of APOBEC1 protein deficiency? 12/03/2019

APOBEC1 protein deficiency can result in the absence of apoB-48 production and an accumulation of full-length APOB mRNA. This condition is known as familial hypocholesterolemia type 2, characterized by reduced levels of low-density lipoprotein (LDL) cholesterol in the blood.

Can APOBEC1 protein cause DNA mutagenesis? 12/12/2018

Yes, APOBEC1 protein, like other APOBEC enzymes, has the potential to cause DNA mutagenesis. When aberrantly expressed or mislocalized in the nucleus, APOBEC1 can act on genomic DNA and induce C-to-U deamination. If not properly repaired, these mutations can lead to genetic alterations and contribute to the development of cancer or other genetic diseases.

How is the activity of APOBEC1 protein regulated? 06/25/2018

The activity of APOBEC1 protein is tightly regulated at multiple levels. It requires the presence of an RNA-binding protein called APOBEC1 complementation factor (ACF) to form a stable complex and efficiently edit APOB mRNA. Additionally, various post-translational modifications, including phosphorylation and acetylation, have been shown to modulate the catalytic activity and stability of APOBEC1 protein.

Can APOBEC1 protein be used as a diagnostic marker for any diseases? 01/14/2017

While APOBEC1 protein is not commonly used as a diagnostic marker, its dysregulation and altered activity have been associated with certain diseases. In the case of liver cancer, increased APOBEC1-mediated RNA editing of APOB mRNA has been observed as a molecular marker. Detecting alterations in APOBEC1 expression or activity may provide insights into disease progression or treatment response. However, further research is needed to establish APOBEC1 as a reliable diagnostic marker for clinical use.

Are there any naturally occurring inhibitors of APOBEC1 protein? 11/25/2016

Yes, several naturally occurring inhibitors of APOBEC1 protein have been identified. For example, RNA-binding protein HuR (Human antigen R) was found to interact with APOBEC1 and suppress its catalytic activity. Additionally, microRNA miR-27a can downregulate APOBEC1 expression and decrease its editing activity. These endogenous inhibitors may play a role in fine-tuning APOBEC1 function and maintaining cellular homeostasis.

How does APOBEC1 protein contribute to viral restriction? 06/27/2016

APOBEC1 and other members of the APOBEC family have demonstrated antiviral activity by inducing mutations in viral genomes. APOBEC1 can target the genomes of retroviruses, such as HIV-1, and introduce C-to-U editing, resulting in hypermutation and degradation of viral genetic material. This innate immune response helps limit viral replication and spread within the host.

Customer Reviews (4)

Write a review
Reviews
11/13/2021

    Its excellent performance in this application makes it a valuable asset in immunoassays and other biochemical studies.

    12/31/2017

      Its utilization in this technique has allowed for precise visualization and determination of protein structures with remarkable clarity and resolution.

      02/01/2017

        I am particularly impressed by APOBEC1 protein's versatility and reliability across different experimental techniques, showcasing its robustness and suitability for a wide range of research applications.

        04/28/2016

          APOBEC1 protein has proved to be an invaluable tool in protein electron microscopy structure analysis.

          Ask a Question for All APOBEC1 Products

          Required fields are marked with *

          My Review for All APOBEC1 Products

          Required fields are marked with *

          0

          Inquiry Basket

          cartIcon
          logo

          FOLLOW US

          Terms and Conditions        Privacy Policy

          Copyright © 2024 Creative BioMart. All Rights Reserved.

          Contact Us

          • /

          Stay Updated on the Latest Bioscience Trends